AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Parlato, S Santini, SM Lapenta, C Di Pucchio, T Logozzi, M Spada, M Glammarioli, AM Malorni, W Fais, S Belardelli, F
Citation: S. Parlato et al., Expression of CCR-7, MIP-3 beta, and Th-1 chemokines in type IIFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities, BLOOD, 98(10), 2001, pp. 3022-3029

Authors: Parlato, S Santini, SM Lapenta, C Spada, M Logozzi, M Rizza, P Proietti, E Belardelli, F Fais, S
Citation: S. Parlato et al., Primary HIV-1 infection of human CD4+T cells passaged into SCID mice leadsto selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells, CELL DEAT D, 7(1), 2000, pp. 37-47

Authors: Mecchia, M Matarrese, P Malorni, W D'Agostino, G Sestili, P Santini, SM Gauzzi, MC Venditti, M Mazzocchi, A Parmiani, G Belardelli, F Ferrantini, M
Citation: M. Mecchia et al., Type I consensus interferon (CIFN) gene transfer into human melanoma cellsup-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha, GENE THER, 7(2), 2000, pp. 167-179

Authors: Santini, SM Lapenta, C Logozzi, M Parlato, S Spada, M Di Pucchio, T Belardelli, F
Citation: Sm. Santini et al., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice, J EXP MED, 191(10), 2000, pp. 1777-1788

Authors: Schiavoni, G Mattei, F Di Pucchio, T Santini, SM Bracci, L Belardelli, F Proietti, E
Citation: G. Schiavoni et al., Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, BLOOD, 95(6), 2000, pp. 2024-2030

Authors: Rozera, C Mecchia, M Gresser, I Bandu, MT Proietti, E Venditti, M Sestili, P Santini, SM Fais, S Belardelli, F Ferrantini, M
Citation: C. Rozera et al., Murine interferon-alpha(1) gene-transduced ESb tumor cells are rejected byhost-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy, CANC GENE T, 6(3), 1999, pp. 246-253

Authors: Lapenta, C Santini, SM Proietti, E Rizza, P Logozzi, M Spada, M Parlato, S Fais, S Pitha, PM Belardelli, F
Citation: C. Lapenta et al., Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells, VIROLOGY, 263(1), 1999, pp. 78-88

Authors: Fais, S Lapenta, C Santini, SM Spada, M Parlato, S Logozzi, M Rizza, P Belardelli, F
Citation: S. Fais et al., Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation differentiation of human target cells at the time of primary infection, J VIROLOGY, 73(8), 1999, pp. 6453-6459

Authors: Lapenta, C Boirivant, M Marini, M Santini, SM Logozzi, M Viora, M Belardelli, F Fais, S
Citation: C. Lapenta et al., Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection, EUR J IMMUN, 29(4), 1999, pp. 1202-1208

Authors: Belardelli, F Ferrantini, M Santini, SM Baccarini, S Proietti, E Colombo, MP Sprent, J Tough, DF
Citation: F. Belardelli et al., The induction of in vivo proliferation of long-lived CD44(hi) CD8(+) T cells after the injection of tumor cells expressing IFN-alpha(1) into syngeneic mice, CANCER RES, 58(24), 1998, pp. 5795-5802
Risultati: 1-10 |